• mail us help@statsmarketresearch.com
  • Int'l (+1)-646-781-7170
  • Asia: (+91)-916-916-4321

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Recombinant Erythropoietin Drugs Market - Global Outlook and Forecast 2022-2028

Recombinant Erythropoietin Drugs Market - Global Outlook and Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 11 January 2022
  • Pages :79
  • Formats:
  • Report Code:SMR-6711046
OfferClick for best price

Best Price: $2600

Erythropoietin (EPO), also known as haematopoietin or haemopoietin, is a glycoprotein cytokine secreted by the kidney in response to cellular hypoxia; it stimulates red blood cell production (erythropoiesis) in the bone marrow. Low levels of EPO (around 10 mU/mL) are constantly secreted sufficient to compensate for normal red blood cell turnover. Common causes of cellular hypoxia resulting in elevated levels of EPO (up to 10 000 mU/mL) include any anemia, and hypoxemia due to chronic lung disease.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. Liver production predominates in the fetal and perinatal period; renal production predominates in adulthood. It is homologous with thrombopoietin.
This report contains market size and forecasts of Recombinant Erythropoietin Drugs in global, including the following market information:
Global Recombinant Erythropoietin Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Erythropoietin Drugs Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Recombinant Erythropoietin Drugs companies in 2021 (%)
The global Recombinant Erythropoietin Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
rhEPO Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Erythropoietin Drugs include Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Roche, 3SBio Group, Celltrion, Inc, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd and LG Life Sciences Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Erythropoietin Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Erythropoietin Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Recombinant Erythropoietin Drugs Market Segment Percentages, by Type, 2021 (%)

  • rhEPO
  • Erythropoiesis-Stimulating Agents (ESA)

Global Recombinant Erythropoietin Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Recombinant Erythropoietin Drugs Market Segment Percentages, by Application, 2021 (%)

  • Chronic Kidney Disease
  • Cancer Related Anemia
  • Others

Global Recombinant Erythropoietin Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Recombinant Erythropoietin Drugs Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

  • Key companies Recombinant Erythropoietin Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
  • Key companies Recombinant Erythropoietin Drugs revenues share in global market, 2021 (%)
  • Key companies Recombinant Erythropoietin Drugs sales in global market, 2017-2022 (Estimated), (KG)
  • Key companies Recombinant Erythropoietin Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Amgen
  • Johnson & Johnson
  • Kyowa Hakko Kirin
  • Roche
  • 3SBio Group
  • Celltrion, Inc
  • Teva Pharmaceutical Industries Ltd
  • F. Hoffmann-La Roche Ltd
  • LG Life Sciences Ltd
  • Biocon Limited
  • Intas Pharmaceuticals Ltd
  • Sun Pharmaceutical Industries Ltd
  • Dr. Reddy's Laboratories Ltd

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Recombinant Erythropoietin Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Erythropoietin Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Erythropoietin Drugs Overall Market Size
2.1 Global Recombinant Erythropoietin Drugs Market Size: 2021 VS 2028
2.2 Global Recombinant Erythropoietin Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Erythropoietin Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Recombinant Erythropoietin Drugs Players in Global Market
3.2 Top Global Recombinant Erythropoietin Drugs Companies Ranked by Revenue
3.3 Global Recombinant Erythropoietin Drugs Revenue by Companies
3.4 Global Recombinant Erythropoietin Drugs Sales by Companies
3.5 Global Recombinant Erythropoietin Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Erythropoietin Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Erythropoietin Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Erythropoietin Drugs Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Erythropoietin Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Erythropoietin Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Erythropoietin Drugs Market Size Markets, 2021 & 2028
4.1.2 rhEPO
4.1.3 Erythropoiesis-Stimulating Agents (ESA)
4.2 By Type - Global Recombinant Erythropoietin Drugs Revenue & Forecasts
4.2.1 By Type - Global Recombinant Erythropoietin Drugs Revenue, 2017-2022
4.2.2 By Type - Global Recombinant Erythropoietin Drugs Revenue, 2023-2028
4.2.3 By Type - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Erythropoietin Drugs Sales & Forecasts
4.3.1 By Type - Global Recombinant Erythropoietin Drugs Sales, 2017-2022
4.3.2 By Type - Global Recombinant Erythropoietin Drugs Sales, 2023-2028
4.3.3 By Type - Global Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Erythropoietin Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Recombinant Erythropoietin Drugs Market Size, 2021 & 2028
5.1.2 Chronic Kidney Disease
5.1.3 Cancer Related Anemia
5.1.4 Others
5.2 By Application - Global Recombinant Erythropoietin Drugs Revenue & Forecasts
5.2.1 By Application - Global Recombinant Erythropoietin Drugs Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Erythropoietin Drugs Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Erythropoietin Drugs Sales & Forecasts
5.3.1 By Application - Global Recombinant Erythropoietin Drugs Sales, 2017-2022
5.3.2 By Application - Global Recombinant Erythropoietin Drugs Sales, 2023-2028
5.3.3 By Application - Global Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Erythropoietin Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Recombinant Erythropoietin Drugs Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Erythropoietin Drugs Revenue & Forecasts
6.2.1 By Region - Global Recombinant Erythropoietin Drugs Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Erythropoietin Drugs Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Erythropoietin Drugs Sales & Forecasts
6.3.1 By Region - Global Recombinant Erythropoietin Drugs Sales, 2017-2022
6.3.2 By Region - Global Recombinant Erythropoietin Drugs Sales, 2023-2028
6.3.3 By Region - Global Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Erythropoietin Drugs Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Erythropoietin Drugs Sales, 2017-2028
6.4.3 US Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.4.4 Canada Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.4.5 Mexico Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Erythropoietin Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Erythropoietin Drugs Sales, 2017-2028
6.5.3 Germany Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.5.4 France Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.5.5 U.K. Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.5.6 Italy Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.5.7 Russia Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.5.9 Benelux Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Erythropoietin Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Erythropoietin Drugs Sales, 2017-2028
6.6.3 China Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.6.4 Japan Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.6.5 South Korea Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.6.7 India Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Erythropoietin Drugs Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Erythropoietin Drugs Sales, 2017-2028
6.7.3 Brazil Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.7.4 Argentina Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Erythropoietin Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Erythropoietin Drugs Sales, 2017-2028
6.8.3 Turkey Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.8.4 Israel Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Erythropoietin Drugs Market Size, 2017-2028
6.8.6 UAE Recombinant Erythropoietin Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Recombinant Erythropoietin Drugs Major Product Offerings
7.1.4 Amgen Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Amgen Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Recombinant Erythropoietin Drugs Major Product Offerings
7.2.4 Johnson & Johnson Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Kyowa Hakko Kirin
7.3.1 Kyowa Hakko Kirin Corporate Summary
7.3.2 Kyowa Hakko Kirin Business Overview
7.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Major Product Offerings
7.3.4 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Kyowa Hakko Kirin Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Recombinant Erythropoietin Drugs Major Product Offerings
7.4.4 Roche Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Roche Key News
7.5 3SBio Group
7.5.1 3SBio Group Corporate Summary
7.5.2 3SBio Group Business Overview
7.5.3 3SBio Group Recombinant Erythropoietin Drugs Major Product Offerings
7.5.4 3SBio Group Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.5.5 3SBio Group Key News
7.6 Celltrion, Inc
7.6.1 Celltrion, Inc Corporate Summary
7.6.2 Celltrion, Inc Business Overview
7.6.3 Celltrion, Inc Recombinant Erythropoietin Drugs Major Product Offerings
7.6.4 Celltrion, Inc Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Celltrion, Inc Key News
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Corporate Summary
7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Teva Pharmaceutical Industries Ltd Key News
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.8.2 F. Hoffmann-La Roche Ltd Business Overview
7.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.8.4 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.8.5 F. Hoffmann-La Roche Ltd Key News
7.9 LG Life Sciences Ltd
7.9.1 LG Life Sciences Ltd Corporate Summary
7.9.2 LG Life Sciences Ltd Business Overview
7.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.9.4 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.9.5 LG Life Sciences Ltd Key News
7.10 Biocon Limited
7.10.1 Biocon Limited Corporate Summary
7.10.2 Biocon Limited Business Overview
7.10.3 Biocon Limited Recombinant Erythropoietin Drugs Major Product Offerings
7.10.4 Biocon Limited Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Biocon Limited Key News
7.11 Intas Pharmaceuticals Ltd
7.11.1 Intas Pharmaceuticals Ltd Corporate Summary
7.11.2 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Business Overview
7.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.11.4 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Intas Pharmaceuticals Ltd Key News
7.12 Sun Pharmaceutical Industries Ltd
7.12.1 Sun Pharmaceutical Industries Ltd Corporate Summary
7.12.2 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Business Overview
7.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.12.4 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Sun Pharmaceutical Industries Ltd Key News
7.13 Dr. Reddy's Laboratories Ltd
7.13.1 Dr. Reddy's Laboratories Ltd Corporate Summary
7.13.2 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Business Overview
7.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Major Product Offerings
7.13.4 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Dr. Reddy's Laboratories Ltd Key News
8 Global Recombinant Erythropoietin Drugs Production Capacity, Analysis
8.1 Global Recombinant Erythropoietin Drugs Production Capacity, 2017-2028
8.2 Recombinant Erythropoietin Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Erythropoietin Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Erythropoietin Drugs Supply Chain Analysis
10.1 Recombinant Erythropoietin Drugs Industry Value Chain
10.2 Recombinant Erythropoietin Drugs Upstream Market
10.3 Recombinant Erythropoietin Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Erythropoietin Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Key Players of Recombinant Erythropoietin Drugs in Global Market
Table 2. Top Recombinant Erythropoietin Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Erythropoietin Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Erythropoietin Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Erythropoietin Drugs Sales by Companies, (KG), 2017-2022
Table 6. Global Recombinant Erythropoietin Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Erythropoietin Drugs Price (2017-2022) & (USD/g)
Table 8. Global Manufacturers Recombinant Erythropoietin Drugs Product Type
Table 9. List of Global Tier 1 Recombinant Erythropoietin Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Erythropoietin Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Erythropoietin Drugs Sales (KG), 2017-2022
Table 15. By Type - Global Recombinant Erythropoietin Drugs Sales (KG), 2023-2028
Table 16. By Application ? Global Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Erythropoietin Drugs Sales (KG), 2017-2022
Table 20. By Application - Global Recombinant Erythropoietin Drugs Sales (KG), 2023-2028
Table 21. By Region ? Global Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Erythropoietin Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Erythropoietin Drugs Sales (KG), 2017-2022
Table 25. By Region - Global Recombinant Erythropoietin Drugs Sales (KG), 2023-2028
Table 26. By Country - North America Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Erythropoietin Drugs Sales, (KG), 2017-2022
Table 29. By Country - North America Recombinant Erythropoietin Drugs Sales, (KG), 2023-2028
Table 30. By Country - Europe Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Erythropoietin Drugs Sales, (KG), 2017-2022
Table 33. By Country - Europe Recombinant Erythropoietin Drugs Sales, (KG), 2023-2028
Table 34. By Region - Asia Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Erythropoietin Drugs Sales, (KG), 2017-2022
Table 37. By Region - Asia Recombinant Erythropoietin Drugs Sales, (KG), 2023-2028
Table 38. By Country - South America Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Erythropoietin Drugs Sales, (KG), 2017-2022
Table 41. By Country - South America Recombinant Erythropoietin Drugs Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Sales, (KG), 2023-2028
Table 46. Amgen Corporate Summary
Table 47. Amgen Recombinant Erythropoietin Drugs Product Offerings
Table 48. Amgen Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Recombinant Erythropoietin Drugs Product Offerings
Table 51. Johnson & Johnson Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 52. Kyowa Hakko Kirin Corporate Summary
Table 53. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product Offerings
Table 54. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 55. Roche Corporate Summary
Table 56. Roche Recombinant Erythropoietin Drugs Product Offerings
Table 57. Roche Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 58. 3SBio Group Corporate Summary
Table 59. 3SBio Group Recombinant Erythropoietin Drugs Product Offerings
Table 60. 3SBio Group Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 61. Celltrion, Inc Corporate Summary
Table 62. Celltrion, Inc Recombinant Erythropoietin Drugs Product Offerings
Table 63. Celltrion, Inc Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 64. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 65. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 66. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 67. F. Hoffmann-La Roche Ltd Corporate Summary
Table 68. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 69. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 70. LG Life Sciences Ltd Corporate Summary
Table 71. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 72. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 73. Biocon Limited Corporate Summary
Table 74. Biocon Limited Recombinant Erythropoietin Drugs Product Offerings
Table 75. Biocon Limited Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 76. Intas Pharmaceuticals Ltd Corporate Summary
Table 77. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 78. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 79. Sun Pharmaceutical Industries Ltd Corporate Summary
Table 80. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 81. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 82. Dr. Reddy's Laboratories Ltd Corporate Summary
Table 83. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product Offerings
Table 84. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 85. Recombinant Erythropoietin Drugs Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 86. Global Recombinant Erythropoietin Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Recombinant Erythropoietin Drugs Production by Region, 2017-2022 (KG)
Table 88. Global Recombinant Erythropoietin Drugs Production by Region, 2023-2028 (KG)
Table 89. Recombinant Erythropoietin Drugs Market Opportunities & Trends in Global Market
Table 90. Recombinant Erythropoietin Drugs Market Drivers in Global Market
Table 91. Recombinant Erythropoietin Drugs Market Restraints in Global Market
Table 92. Recombinant Erythropoietin Drugs Raw Materials
Table 93. Recombinant Erythropoietin Drugs Raw Materials Suppliers in Global Market
Table 94. Typical Recombinant Erythropoietin Drugs Downstream
Table 95. Recombinant Erythropoietin Drugs Downstream Clients in Global Market
Table 96. Recombinant Erythropoietin Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Erythropoietin Drugs Segment by Type
Figure 2. Recombinant Erythropoietin Drugs Segment by Application
Figure 3. Global Recombinant Erythropoietin Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Recombinant Erythropoietin Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Erythropoietin Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Erythropoietin Drugs Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Erythropoietin Drugs Revenue in 2021
Figure 9. By Type - Global Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Erythropoietin Drugs Price (USD/g), 2017-2028
Figure 12. By Application - Global Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Erythropoietin Drugs Price (USD/g), 2017-2028
Figure 15. By Region - Global Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
Figure 19. US Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
Figure 33. China Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Erythropoietin Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Erythropoietin Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Erythropoietin Drugs Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production Recombinant Erythropoietin Drugs by Region, 2020 VS 2027
Figure 50. Recombinant Erythropoietin Drugs Industry Value Chain
Figure 51. Marketing Channels

PURCHASE OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount